TAP downregulation by an aptamer-siRNA conjugate could potentiate responsiveness to immune therapy Oct. 18, 2019
Shanghai Institute of Materia Medica and Jinan University patent AXL and/or FLT3 inhibitors Oct. 18, 2019
New apoptosis regulator Bcl-2 inhibitors disclosed by Jiangsu Chia Tai Tianqing Pharmaceutical Group Oct. 18, 2019
Topline results presented from first cohort of phase II study of low-dose inarigivir plus Vemlidy Oct. 18, 2019
RSS